US FDA Urged To Drop Snail Mail For IND Communications

 
• By Derrick Gingery

Waiting for paper letters to arrive can delay drug development, companies contend, but moving completely to e-communication may be difficult for the FDA.

Letter Envelop Message Notification Concept
Industry representatives said the FDA should rely on email for formal communications and stop using snail mail. • Source: Shutterstock

More from US FDA

More from Agency Leadership